Skip to content

disease.nz

Your Daily Health News
Main navigation
Medical Editor March 18, 2022

Merck’s Keytruda reduced risk of disease recurrence or death in early lung cancer patients by 24% – CNBC

Merck’s Keytruda reduced risk of disease recurrence or death in early lung cancer patients by 24%  CNBC
Bookmark the permalink.

Recent Posts

  • Research reveals structure of a human endogenous reverse transcriptase
  • How bacteria adhere to cells: Basis for the development of a new class of antibiotics
  • Some viruses make you smell tastier to mosquitoes
  • Sport-loving teen’s body shut down by rare autoimmune disease – Stuff
  • Carbon monoxide foam in the rectum eases bowel disease in mice – New Scientist

Recent Comments

    Proudly powered by WordPress | Theme: Hive Lite by Pixelgrade.
    Footer navigation
    • Privacy Policy